Onco-Nephrology Symposium 2017
In-Person Event
Dec 01, 2017
New York City, New York, USA
OVERVIEW
Onco-Nephrology Symposium is organized by Memorial Sloan Kettering Cancer Center and will be held on Dec 01, 2017 at Mortimer B. Zuckerman Research Center, New York, United States of America.
The target audience for this medical event is physicians and healthcare professionals in Hospital Medicine, Internal Medicine, Nephrology and Oncology. This CME Conference has been approved for a maximum of 7.75 AMA PRA Category 1 Credits.
Course Description :
Cancer patients present the nephrologist with more complex fluid and electrolyte disturbances than those typically encountered, and the introduction of novel anti-cancer drugs with fairly unique toxicities has created the need for specialized education in the field of onco-nephrology. This seminar will enable participants to advance and refine their understanding of unique issues relating to the evaluation and management of patients with cancer with acquired and chronic kidney disease. Didactic lectures will focus on electrolyte derangements in cancer patients, targeted therapies and their nephrotoxic effects, recognition and management of monoclonal gammopathy of renal significance, acute and chronic kidney disease in the bone marrow transplant patient, anemia management in cancer patients, and care of the renal transplant patient with cancer. Participants will learn about common urinary diversion procedures in these patients and their related complications. Additionally attendees will participate in clinicopathologic case presentations.
This course is directly provided by Memorial Sloan Kettering and in collaboration with MD Anderson Cancer Center. This course is endorsed by the American Society of Nephrology (ASN) and the International Society of Nephrology (ISN).
Conference Objectives :
• Recognize the clinical and laboratory features of the variety of sodium disorders in cancer patients
• Identify the clinical and laboratory features of renal toxicities across a spectrum of cancer chemotherapies
• Identify the clinical and laboratory features of monoclonal gammopathy of renal significance • Manage specific categories of patients with AKI or CKD including bone marrow transplant patients and renal transplants patients diagnosed with cancer
• Evaluate and manage the patient with a renal mass or renal cancer
• Understand the differences among various urinary diversion procedures and the fluid and electrolyte disorders associated with them
Additional details will be posted as soon as they are available.
The target audience for this medical event is physicians and healthcare professionals in Hospital Medicine, Internal Medicine, Nephrology and Oncology. This CME Conference has been approved for a maximum of 7.75 AMA PRA Category 1 Credits.
Course Description :
Cancer patients present the nephrologist with more complex fluid and electrolyte disturbances than those typically encountered, and the introduction of novel anti-cancer drugs with fairly unique toxicities has created the need for specialized education in the field of onco-nephrology. This seminar will enable participants to advance and refine their understanding of unique issues relating to the evaluation and management of patients with cancer with acquired and chronic kidney disease. Didactic lectures will focus on electrolyte derangements in cancer patients, targeted therapies and their nephrotoxic effects, recognition and management of monoclonal gammopathy of renal significance, acute and chronic kidney disease in the bone marrow transplant patient, anemia management in cancer patients, and care of the renal transplant patient with cancer. Participants will learn about common urinary diversion procedures in these patients and their related complications. Additionally attendees will participate in clinicopathologic case presentations.
This course is directly provided by Memorial Sloan Kettering and in collaboration with MD Anderson Cancer Center. This course is endorsed by the American Society of Nephrology (ASN) and the International Society of Nephrology (ISN).
Conference Objectives :
• Recognize the clinical and laboratory features of the variety of sodium disorders in cancer patients
• Identify the clinical and laboratory features of renal toxicities across a spectrum of cancer chemotherapies
• Identify the clinical and laboratory features of monoclonal gammopathy of renal significance • Manage specific categories of patients with AKI or CKD including bone marrow transplant patients and renal transplants patients diagnosed with cancer
• Evaluate and manage the patient with a renal mass or renal cancer
• Understand the differences among various urinary diversion procedures and the fluid and electrolyte disorders associated with them
Additional details will be posted as soon as they are available.
KEY DATES
01 Dec, 2017
Event Start Date
01 Dec, 2017
Event End Date
SPECIALITIES
NephrologySUGGESTED HOTELS
CONFERENCE VENUE
Mortimer B. Zuckerman Research CenterRELATED CONFERENCES & LIVE WEBINARS
Quick Links